-+ 0.00%
-+ 0.00%
-+ 0.00%

PURETECH FOUNDED ENTITY SEAPORT THERAPEUTICS REPORTS POSITIVE MULTIPLE-ASCENDING DOSE DATA FROM PHASE 1 PROOF-OF-CONCEPT TRIAL OF GLYPHAGO™ IN HEALTHY VOLUNTEERS

Reuters·06/09/2026 06:00:00

Please log in to view news